Lanean...
Changed terms for drug payment influenced GPs’ diagnoses and prescribing practice for inhaled corticosteroids
BACKGROUND: Inhaled glucocorticosteroids (ICS) are first-line anti-inflammatory treatment in asthma, but not in chronic obstructive pulmonary disease (COPD). To restrict ICS use in COPD to cases of severe disease, new terms for reimbursement of drug costs were introduced in Norway in 2006, requiring...
Gorde:
| Egile Nagusiak: | , , , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Informa Healthcare
2013
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3696339/ https://ncbi.nlm.nih.gov/pubmed/23560809 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3109/13814788.2013.766713 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|